• Paradigm shift in therapeutic
    vaccination & immunotherapies

  • cutting-edge technology
    in oncology & infectious diseases

  • first-ever human vaccination
    proof-of-concept of lentiviral vectors


our science

Lead the paradigm shift in vaccination &
immunotherapy with a proprietary patent-
protected lentiviral vector technology platform

our pipeline

Bring to market valuable and
affordable treatments against cancer &
major global infectious diseases

Our trials

Develop therapeutic vaccines and
innovative immunotherapies to fight cancer &
infectious diseases